Understanding pharmacogenomic testing and its role in medicine prescribing

Youssef, Essra, Buck, Jackie and Wright, David (2020) Understanding pharmacogenomic testing and its role in medicine prescribing. Nursing Standard, 35 (7). pp. 55-60. ISSN 0029-6570

[img]
Preview
PDF (Accepted_Manuscript) - Submitted Version
Download (311kB) | Preview

Abstract

When making prescribing decisions, it is important for healthcare professionals to remember that individual patients may respond differently to medicines. For example, some patients may experience a therapeutic benefit while others may experience an adverse drug reaction. The aim of personalised medicine is to tailor treatment based not only on a patient's clinical factors, but also on their genetic profile. Pharmacogenomics is a branch of personalised medicine that is concerned with how differences in people's genomes affect their response to medicines. Pharmacogenomic testing, which recently has become less expensive and increasingly available, can inform nurses' prescribing decisions and improve patient outcomes. This article discusses personalised medicine and pharmacogenomics, including how pharmacogenomic testing can optimise medicine prescribing, and explains the role of nurses in the process.

Item Type: Article
Uncontrolled Keywords: pharmacogenomics,prescribing,medicines,pharmacists,adverse reactions,professional,clinical,nurse prescribing,genetics,ethical issues,genetic testing,pharmacology,genomics,medicine(all) ,/dk/atira/pure/subjectarea/asjc/2700
Faculty \ School: Faculty of Science > School of Pharmacy
Faculty of Medicine and Health Sciences > School of Health Sciences
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 02 Jun 2020 00:14
Last Modified: 25 Sep 2020 23:52
URI: https://ueaeprints.uea.ac.uk/id/eprint/75420
DOI: 10.7748/ns.2020.e11543

Actions (login required)

View Item View Item